Covid 19

Our warmest congratulations to our long term partners at GENOMICA SAU for achieving CE-IVD approval for their diagnostic kits against the COVID-19.

Repado, as GENOMICA’s Software Partner for its CAR® and AUTOCLART® Plus Solutions that use the CLART® technology, is proud and will continue to actively support GENOMICA worldwide in the COVID-19 fight.

CLART® technology used by GENOMICA has the capacity to simultaneously analyze 96 patient samples in less than 5 hours, while the GENOMICA diagnostic kits are highly sensitive and specific in detecting COVID-19, even before the patient shows symptoms!